Robinhood Traders Love These 2 Coronavirus Vaccine Stocks, But Should You?
If you've been following the race to discover a coronavirus vaccine, it won't be any shock to hear that both Moderna Therapeutics (NASDAQ: MRNA) and Inovio Pharmaceuticals (NASDAQ: INO) are among the top 100 most-traded stocks on Robinhood. Between their vigorous price movements in the last five months and their consistently advancing vaccine programs, each company's market cap has ballooned to unpredictable heights far in excess of the pre-pandemic norms.
Even if these stocks present the opportunity for speculators to make a quick profit, skeptics are quick to point out that neither company has any products approved for sale. Nor do they have favorable performance or price characteristics. While these minor quibbles might not be very convincing to Robinhood traders, if you're evaluating these two stocks for a long-term portfolio, it's critical to understand which investing metrics to monitor and why so you can make an informed decision.
Image source: Getty Images.
Source Fool.com
